{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T14:31:56Z","timestamp":1774103516322,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11908-019-0667-8","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T08:08:34Z","timestamp":1553069314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safe Travel Preparation for HIV-Infected Patients"],"prefix":"10.1007","volume":"21","author":[{"given":"David","family":"Mariano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darvin Scott","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"667_CR1","unstructured":"\u2022\u2022 Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel. New York: Oxford University Press; 2017. p. 153\u2013154, 233\u2013235, 342\u2013343, 352\u2013354, 557\u2013571. The 2018 CDC Yellow Book is the most up-to-date guide for international travel disease risk by the Centers for Disease Control, and includes information on immunocompromised individuals and vaccination recommendations, and thus is of greatest importance for this review."},{"key":"667_CR2","unstructured":"\u2022 Vaccine Recommendations and Guidelines of the ACIP. In: Centers for Disease Control and Prevention, 2018. \n                      https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/index.html\n                      \n                    . Accessed 17 Sep 2018. This source from the Centers for Disease Control provides information on their current vaccination recommendations."},{"key":"667_CR3","unstructured":"Yellow fever global annual reported cases and YFV coverage, 1980-2016 In: Yellow fever: maps and graphics. World Health Organization, 2017. \n                      http:\/\/www.who.int\/emergencies\/yellow-fever\/maps\/en\/\n                      \n                    ."},{"issue":"11","key":"667_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.15585\/mmwr.mm6711e1","volume":"67","author":"Davidson H. Hamer","year":"2018","unstructured":"Hamer DH, Angelo K, Caumes E, van Genderen PJ, Florescu SA, Popescu CP, et al. Fatal yellow fever in travelers to Brazil, 2018. Morb Mortal Wkly Rep. 2018;67(11):340\u20131.","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"667_CR5","doi-asserted-by":"publisher","unstructured":"Barte, H., Horvath, T.H. and Rutherford, G.W., 2014. Yellow fever vaccine for patients with HIV infection. Cochrane Database Syst Rev, (1), pp.CD010929. \n                      https:\/\/doi.org\/10.1002\/14651858.CD010929.pub2\n                      \n                    .","DOI":"10.1002\/14651858.CD010929.pub2"},{"issue":"6","key":"667_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jinf.2016.02.017","volume":"72","author":"R.W. Wieten","year":"2016","unstructured":"\u2022 Wieten RW, Goorhuis A, Jonker EFF, de Bree GJ, de Visser AW, van Genderen PJJ, et al. 17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immunocompromised patients. J Infect. 2016;72(6):713\u201322. This is a recent study looking at the effects of the yellow fever vaccination in immunocompromised persons.","journal-title":"Journal of Infection"},{"key":"667_CR7","unstructured":"\u2022 New yellow fever vaccination requirements for travellers. In: World Health Organization. WHO. 2016. \n                      http:\/\/www.who.int\/ith\/updates\/20160727\/en\/\n                      \n                    . This is an updated recommendation by the World Health Organization on yellow fever vaccination for international travel."},{"issue":"23","key":"667_CR8","first-page":"647","volume":"64","author":"JE Staples","year":"2015","unstructured":"Staples JE, Bocchini JJ, Rubin L, Fischer M. Yellow fever vaccine booster doses: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb. Mortal. Wkly Rep. 2015;64(23):647\u201350.","journal-title":"MMWR Morb. Mortal. Wkly Rep"},{"key":"667_CR9","unstructured":"Vaccination. In: Typhoid fever and paratyphoid fever. Centers for Disease Control and Prevention. 2018. \n                      https:\/\/www.cdc.gov\/typhoid-fever\/typhoid-vaccination.html\n                      \n                    . Accessed Sep 2018"},{"issue":"23","key":"667_CR10","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMoa054493","volume":"354","author":"D Saha","year":"2006","unstructured":"Saha D, Karim MM, Khan WA, Ahmed S, Salam MA, Bennish ML. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med. 2006;354(23):2452\u201362.","journal-title":"N Engl J Med"},{"key":"667_CR11","unstructured":"\u2022 Grading of recommendations, assessment, development, and evaluation (GRADE) for Lyophilized CVD 103-HgR Vaccine. In: Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. 2017. \n                      https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/cholera-CVD-103-HgR.html\n                      \n                    . This important source provides information on the newly developed cholera vaccination."},{"key":"667_CR12","unstructured":"Perry RT, Plowe CV, Koumare B, Bougoudogo F, Kotloff KL, Losonsky GA, et al. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bull World Health Organ. 1998;76(1):63\u201371."},{"issue":"3","key":"667_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/infdis\/jiv060","volume":"212","author":"HM Garcia Garrido","year":"2015","unstructured":"Garcia Garrido HM, Wieten RW, Grobusch MP, Goorhuis A. Response to hepatitis A vaccination in immunocompromised travelers. J Infect Dis. 2015;212(3):378\u201385.","journal-title":"J Infect Dis"},{"key":"667_CR14","unstructured":"Choosing a Drug to Prevent Malaria. In: Malaria. Centers for Disease Control and Prevention. 2018. \n                      https:\/\/www.cdc.gov\/malaria\/travelers\/drugs.html\n                      \n                    . Accesed Sep 2018"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-019-0667-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-019-0667-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-019-0667-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:25:22Z","timestamp":1584577522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-019-0667-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1007\/s11908-019-0667-8","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"20 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"David Mariano and Darvin Scott Smith declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"15"}}